← Back to Search

Behavioral Intervention

BESTOW behavioral intervention for Binge Eating (BESTOW Trial)

N/A
Waitlist Available
Led By Lisa Kilpela, PhD
Research Sponsored by The University of Texas Health Science Center at San Antonio
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to 16 weeks, 1 month, and 2 month follow-up
Awards & highlights

BESTOW Trial Summary

This trial studies the effects of a cognitive-behavioral intervention on 20 older women. Assessments will be taken at different points.

Eligible Conditions
  • Binge Eating

BESTOW Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to 16 weeks, 1 month, and 2 month follow-up
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to 16 weeks, 1 month, and 2 month follow-up for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Acceptability - Usage Rating Profile - Intervention
Feasibility - Usage Rating Profile - Intervention
Secondary outcome measures
Binge Eating Score (BES)
Geriatric Depression Scale Score (Center for Epidemiologic Studies-Depression Scale; CES-D)

BESTOW Trial Design

1Treatment groups
Experimental Treatment
Group I: BESTOW behavioral interventionExperimental Treatment1 Intervention
The intervention will utilize behavioral-based strategies to reduce BE and improve health behaviors, with content including strategies to improve body image, regulation of eating behaviors, and integration of physical activity with an emphasis on body function, health, and longevity.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Binge Eating Syndrome Treatment (BESTOW)
2023
N/A
~30

Find a Location

Who is running the clinical trial?

The University of Texas Health Science Center at San AntonioLead Sponsor
452 Previous Clinical Trials
91,393 Total Patients Enrolled
National Institute on Aging (NIA)NIH
1,671 Previous Clinical Trials
28,017,042 Total Patients Enrolled
Lisa Kilpela, PhDPrincipal InvestigatorUniversity of Texas Health Science Center San Antonio

Media Library

Binge Eating Syndrome Treatment (BESTOW) (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05806788 — N/A
Binge Eating Research Study Groups: BESTOW behavioral intervention
Binge Eating Clinical Trial 2023: Binge Eating Syndrome Treatment (BESTOW) Highlights & Side Effects. Trial Name: NCT05806788 — N/A
Binge Eating Syndrome Treatment (BESTOW) (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05806788 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the recruitment process for this research study still open?

"Indeed, the data hosted on clinicaltrials.gov shows that this medical trial is presently in search of volunteers. It was originally announced on February 17th 2023 and has recently been updated as of April 6th 2023. The research requires a total of 20 participants at one location to be recruited."

Answered by AI

What is the aggregate population of participants engaging in this medical investigation?

"Affirmative, the information provided on clinicaltrials.gov demonstrates that this medical trial is actively seeking volunteers. The study was first published on February 17th 2023 and has been amended for modernity as recently as April 6th 2023. Presently, recruitment efforts are underway to fill up a quota of 20 participants at 1 site."

Answered by AI
~10 spots leftby Apr 2025